Investor Relations Representative
IR Representative
Replay available
Voyager Therapeutics, Inc. (VYGR) Q4 2024 Earnings Call
Voyager Therapeutics, Inc. (NASDAQ: VYGR) Q4 2024 earnings conference call, held 2025-03-11. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Dr. Al Sandrock
Chief Executive Officer
Dr. Toby Ferguson
Chief Medical Officer
Dr. Nathan Jorgensen
Chief Financial Officer
Trista Morrison
Chief Corporate Affairs Officer
Phil Navy
TD Cowan
Dr. Todd Carter
Chief Scientific Officer
Jack Allen
Baird
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Voyager Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.537 good afternoon and welcome to voyager therapeutics fourth quarter and year-end 2024 financial 00:00:05.537 -- 00:00:10.443 results conference call at this time all participants are in a listen-only mode there 00:00:10.443 -- 00:00:14.628 will be a question and answer session at the end of this call please note that today's 00:00:14.628 -- 00:00:19.894 call is being recorded a replay of today's call will be available on in the arrest investors 00:00:19.894 -- 00:00:25.240 section of the company website approximately two hours after the completion of this call 00:00:25.240 -- 00:00:29.832 i would now like to turn the call over to trista morrison Chief Corporate Affairs Officer 00:00:29.832 -- 00:00:31.932 at Voyager. 00:00:34.456 -- 00:00:39.660 Good afternoon. We issued our fourth quarter and year-end 2024 financial 00:00:39.660 -- 00:00:44.725 results press release this afternoon. The press release and 10-K are available on our 00:00:44.725 -- 00:00:50.250 website. On today's call, Dr. Al Sandrock, our Chief Executive Officer, 00:00:50.250 -- 00:00:55.014 will briefly review key recent and upcoming milestones, and we will reserve most of our 00:00:55.014 -- 00:00:59.363 time for your Q&A. Joining us for Q&A are Dr. 00:00:59.363 -- 00:01:02.867 Toby Ferguson, our Chief Medical Officer, Dr. 00:01:02.867 -- 00:01:06.411 Todd Carter, our Chief Scientific Officer, and Dr. 00:01:06.411 -- 00:01:10.015 Nathan Jorgensen, our Chief Financial Officer. 00:01:10.015 -- 00:01:14.019 Before we get started, I would like to remind everyone that during this call, Voyager 00:01:14.019 -- 00:01:18.404 representatives may make forward-looking statements, as noted in slide two of today's 00:01:18.404 -- 00:01:23.089 deck. These statements are based on ...